Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07213245 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Metabolic Effects of Short-term Ultra-processed Food Intake (MEST-UPF)

StatusRecruiting
PhaseNot applicable
Started2025-12-01
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 8 months later Apr 30, 2026 → Dec 31, 2026
See other at-risk trials from Göteborg University

Amendment history

2026-09-08
critical
Study Status v3
Primary completion pushed: 2026-04-30 → 2026-12-31
Completion pushed: 2026-04-30 → 2026-12-31
2025-12-12
minor
Study Status v2
Re-verified, no change to tracked fields
2025-11-25
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start date2025-11-01→2025-12-01
Study sitesdetails revised at 1 of 1 site
2025-10-01
minor
Original filing
3,523 trials monitored
See 133 trials at risk
The overall aim of this project is to study the effects of short-term high ultra-processed food intake, compared to nutrient- and energy density matched low ultra-processed food (UPF) intake, on energy intake and appetite. A total of 24 men and women who meet all inclusion criteria and none of the exclusion criteria will be invited to participate. A randomized 2\*2 factorial four-way crossover study will be conducted at the Department of Internal medicine and Clinical Nutrition at the University of Gothenburg, comparing a high-UPF meal to a low-UPF meal also with high and/or low energy density. A supervised breakfast meal will be served, and postprandial blood samples and appetite measures will be collected continuously up to 4 hours after the breakfast meal. Subsequently, an ad libitum lunch meal will be served, and energy intake will be recorded.
Trial Details
NCT Number NCT07213245
Lead Sponsor Göteborg University
Conditions Appetite, Obesity and Obesity-related Medical Conditions
Enrollment 24 participants
Start Date 2025-12-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-09